SK287510B6 - Použitie darifenacínu alebo jeho farmaceuticky prijateľného derivátu na prípravu liečiva na zmierňovanie nutkania na močenie u pacientov trpiacich suchým hyperaktívnym mechúrom - Google Patents

Použitie darifenacínu alebo jeho farmaceuticky prijateľného derivátu na prípravu liečiva na zmierňovanie nutkania na močenie u pacientov trpiacich suchým hyperaktívnym mechúrom Download PDF

Info

Publication number
SK287510B6
SK287510B6 SK250-2004A SK2502004A SK287510B6 SK 287510 B6 SK287510 B6 SK 287510B6 SK 2502004 A SK2502004 A SK 2502004A SK 287510 B6 SK287510 B6 SK 287510B6
Authority
SK
Slovakia
Prior art keywords
darifenacin
pharmaceutically acceptable
acceptable derivative
overactive bladder
urgency
Prior art date
Application number
SK250-2004A
Other languages
English (en)
Slovak (sk)
Other versions
SK2502004A3 (en
Inventor
Enrico Colli
Paul Quinn
Dzelal Serdarevic
Laurence Howard Skillern
Original Assignee
Novartis International Pharmaceutical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9927643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287510(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis International Pharmaceutical Ltd. filed Critical Novartis International Pharmaceutical Ltd.
Publication of SK2502004A3 publication Critical patent/SK2502004A3/sk
Publication of SK287510B6 publication Critical patent/SK287510B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Document Processing Apparatus (AREA)
  • Processing Of Meat And Fish (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Inorganic Insulating Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
SK250-2004A 2001-12-14 2002-03-05 Použitie darifenacínu alebo jeho farmaceuticky prijateľného derivátu na prípravu liečiva na zmierňovanie nutkania na močenie u pacientov trpiacich suchým hyperaktívnym mechúrom SK287510B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129962.7A GB0129962D0 (en) 2001-12-14 2001-12-14 Method of treatment
PCT/IB2002/000664 WO2003051354A1 (en) 2001-12-14 2002-03-05 Method of treatment

Publications (2)

Publication Number Publication Date
SK2502004A3 SK2502004A3 (en) 2004-10-05
SK287510B6 true SK287510B6 (sk) 2010-12-07

Family

ID=9927643

Family Applications (1)

Application Number Title Priority Date Filing Date
SK250-2004A SK287510B6 (sk) 2001-12-14 2002-03-05 Použitie darifenacínu alebo jeho farmaceuticky prijateľného derivátu na prípravu liečiva na zmierňovanie nutkania na močenie u pacientov trpiacich suchým hyperaktívnym mechúrom

Country Status (28)

Country Link
US (3) US20030130338A1 (ru)
EP (1) EP1458376B1 (ru)
JP (3) JP2005516925A (ru)
KR (1) KR100889086B1 (ru)
CN (1) CN100488505C (ru)
AT (1) ATE341323T1 (ru)
AU (1) AU2002236141B2 (ru)
BR (1) BR0214925A (ru)
CA (1) CA2469702C (ru)
CY (1) CY1105814T1 (ru)
CZ (1) CZ301283B6 (ru)
DE (1) DE60215219T2 (ru)
DK (1) DK1458376T3 (ru)
ES (1) ES2276910T3 (ru)
GB (1) GB0129962D0 (ru)
HK (1) HK1073779A1 (ru)
HU (1) HU229908B1 (ru)
IL (2) IL162391A0 (ru)
MX (1) MXPA04005760A (ru)
NO (1) NO20042586L (ru)
NZ (1) NZ533421A (ru)
PL (1) PL206034B1 (ru)
PT (1) PT1458376E (ru)
RU (1) RU2321398C2 (ru)
SI (1) SI1458376T1 (ru)
SK (1) SK287510B6 (ru)
WO (1) WO2003051354A1 (ru)
ZA (1) ZA200404289B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090062326A1 (en) * 2006-03-17 2009-03-05 Spindel Eliot R M3 muscarinic receptor antagonists for treatment of m3 muscarinic receptor-expressing tumors
CN101084891A (zh) * 2007-06-29 2007-12-12 北京本草天源药物研究院 一种用于口服的达非那新或其药用盐的药物制剂
CZ300895B6 (cs) * 2008-01-28 2009-09-02 Zentiva, A. S. Zpusob prípravy Darifenacinu
ES2603747T3 (es) * 2009-02-04 2017-03-01 Astellas Pharma Inc. Composición farmacéutica para administración oral
CN102048706B (zh) * 2011-01-12 2012-02-22 山东创新药物研发有限公司 一种氢溴酸达非那新缓释片及制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
GB9518953D0 (en) * 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations

Also Published As

Publication number Publication date
NO20042586L (no) 2004-06-18
DE60215219D1 (de) 2006-11-16
IL162391A0 (en) 2005-11-20
RU2004121780A (ru) 2005-08-10
CA2469702A1 (en) 2003-06-26
ZA200404289B (en) 2005-09-28
US20090162433A1 (en) 2009-06-25
WO2003051354A1 (en) 2003-06-26
AU2002236141A1 (en) 2003-06-30
HU229908B1 (hu) 2014-12-29
ES2276910T3 (es) 2007-07-01
JP2005516925A (ja) 2005-06-09
DE60215219T2 (de) 2007-10-18
MXPA04005760A (es) 2005-03-31
JP2010024244A (ja) 2010-02-04
US8748476B2 (en) 2014-06-10
CN100488505C (zh) 2009-05-20
EP1458376A1 (en) 2004-09-22
DK1458376T3 (da) 2007-02-12
SK2502004A3 (en) 2004-10-05
NZ533421A (en) 2007-02-23
HK1073779A1 (en) 2005-10-21
HUP0402625A2 (hu) 2005-04-28
PT1458376E (pt) 2007-01-31
CZ2004719A3 (cs) 2005-01-12
RU2321398C2 (ru) 2008-04-10
CA2469702C (en) 2010-07-06
AU2002236141B2 (en) 2007-02-01
CZ301283B6 (cs) 2009-12-30
IL162391A (en) 2012-04-30
PL369426A1 (en) 2005-04-18
US20070264333A1 (en) 2007-11-15
BR0214925A (pt) 2004-12-21
EP1458376B1 (en) 2006-10-04
PL206034B1 (pl) 2010-06-30
CN1604777A (zh) 2005-04-06
JP2013199506A (ja) 2013-10-03
ATE341323T1 (de) 2006-10-15
US20030130338A1 (en) 2003-07-10
CY1105814T1 (el) 2011-02-02
KR100889086B1 (ko) 2009-03-16
KR20040066892A (ko) 2004-07-27
SI1458376T1 (sl) 2007-06-30
GB0129962D0 (en) 2002-02-06

Similar Documents

Publication Publication Date Title
BRPI0618239A2 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusico
JP2013199506A (ja) 処置方法
HU215959B (hu) Eljárás 5-metil-izoxazol-4-karbonsav-anilideket vagy 2-hidroxi-etilidén ciano-ecetsav-anilideket tartalmazó, szembetegségek kezelésére helyileg alkalmazható gyógyszerkészítmények előállítására
US20040087644A1 (en) Pharmaceutical composition in capsules that comprises a non-steroidal antiinflamatory and an optiate analgesic for handling pain
JP3792251B2 (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
Ribard et al. Rheumatological side-effects of quinolones
JP2000080046A (ja) 多臓器障害の予防・治療剤
KR100692235B1 (ko) 안지오텐신 ⅱ 길항물질의 신규한 용도
EP2727595B1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
JP6894555B1 (ja) 排尿症状治療剤
JPH10120592A (ja) メニエール病乃至メニエール症候群治療剤
US20040116451A1 (en) Method of treatment
AU2003259464A1 (en) Use of a quinazoline derivative for treating lower urinary tract symptoms
CN115715191A (zh) 排尿症状治疗剂
JPH0578249A (ja) ５−フルオロウラシル類により起こる嘔気・嘔吐の防止及び治療剤

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: MERUS LABS LUXCO SARL, LUXEMBOURG, LU

Free format text: FORMER OWNER: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD., HAMILTON, BM

Effective date: 20130422

PC4A Assignment and transfer of rights

Owner name: MERUS LABS LUXCO II S.A R.L., LUXEMBOURG, LU

Free format text: FORMER OWNER: MERUS LABS LUXCO SARL, LUXEMBOURG, LU

Effective date: 20180627

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20200305